AngioDynamics, Inc.

NASDAQ:ANGO

Medical - Instruments & Supplies

Healthcare
$11.32 +1.71%

+$0.20 today

Market cap
$476.06M
Beta
0.36
P/E (TTM)
-15.8
EPS (TTM)
-$0.75
52W Low $8.36High $13.99

Volume 0.32M

Average 0.40M

ANGO Intangible Assets

Identifiable non-physical assets such as patents, trademarks, licenses, and customer relationships.

AngioDynamics, Inc.NASDAQ: ANGO

Intangible Assets · Q3 FY2026 · quarter ended Feb 2026

Intangible assets falls 7.7% from a year ago

Intangible assets stood at $65.49M at the end of Q3 FY2026, down 7.7% from a year earlier and down 1.9% from the prior quarter. Over 3 fiscal years it compounded at -23.2% a year.

Context

  • Intangible assets amounted to 25.1% of total assets at the end of Q3 FY2026, up 0.3 pp from a year earlier.
  • Intangible assets increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether intangible assets keeps falling in the next quarterly balance sheet after a -7.7% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterFeb 2026
$65.49M-1.9% QoQ
Last fiscal yearMay 2025
$69.12M-10.7% YoY
Year agoFeb 2025
$70.93M-7.7% since
Intangible Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-7.7%——
1 year-10.7%——
3-year CAGR-23.2%——
5-year CAGR——
10-year CAGR——

Intangible Assets history

USD · from the balance sheet

Latest · FY2025
69.12M USD
Year-over-year change
-10.7%
4-year CAGR
-20.0%

Intangible Assets vs competitors

How ANGO compares with its peers on the latest reported figures

  • ANGO's Feb 2026 intangible assets of $65.49M is the 5th highest of the 9 companies compared; the peer median is $302.74M.
  • Its year-over-year change of -7.7% is the 4th highest of 9, against a peer median of -10.1%.
  • Intangible assets amounts to 25.1% of total assets for ANGO, versus a peer median of 15.3%.
ANGO Competitors Peer median
Intangible Assets for ANGO and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
BSXBoston Scientific CorporationJun 2026$6.92B -4.7%+5.9%15.3%
TFXTeleflex IncorporatedJun 2026$1.45B -33.7%-12.9%21.3%
IARTIntegra LifeSciences Holdings CorporationMar 2026$1.11B -6.9%+0.2%30.9%
CNMDCONMED CorporationMar 2026$573.8M -5.9%-5.1%24.8%
ANGOAngioDynamics, Inc.Feb 2026$65.49M -7.7%-23.2%25.1%
LMATLeMaitre Vascular, Inc.Mar 2026$31.67M -7.9%-10.7%5.0%
PENPenumbra, Inc.Jun 2026$5.74M -12.4%-57.9%0.3%
BDXBecton, Dickinson and CompanySep 2026$0 -100.0%—0.0%
MMSIMerit Medical Systems, Inc.Sep 2026$0 -100.0%+24.9%—
Peer median (excluding ANGO) $302.74M-10.1%-5.1%15.3%

Competitors are the stored peer set for ANGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
May 2021
FY2022
May 2022
FY2023
May 2023
FY2024
May 2024
FY2025
May 2025
Cash & Equivalents48.16M28.83M44.62M76.06M55.89M
Short-term Investments00000
Net Receivables37.32M56.5M52.83M50.01M43.14M
Inventory48.61M51.39M55.33M60.62M62.01M
Other Current Assets1.76M2.2M7.26M2.58M3.07M
Total Current Assets140.88M143.35M163.54M193.25M168.32M
Property, Plant & Equipment (Net)37.07M45.01M44.38M35.67M32.3M
Goodwill201.32M201.06M159.24M00
Intangible Assets168.98M152.38M111.14M77.38M69.12M
Long-term Investments00000
Tax Assets00000
Other Non-current Assets13.19M10.96M54.33M11.37M10.4M
Total Non-current Assets420.56M409.41M369.1M124.42M111.82M
Total Assets561.44M552.75M532.64M317.67M280.14M
Account Payables19.63M28.05M40.45M37.75M33.29M
Short-term Debt08.78M14.76M4.73M400K
Tax Payables631K750K480K520K0
Deferred Revenue00000
Other Current Liabilities3.04M2.71M2.26M9.06M5.52M
Total Current Liabilities57.58M74.32M83.83M91.16M76.2M
Long-term Debt20M25M49.82M05.8M
Deferred Tax Liabilities19.96M16.04M12.81M4.85M0
Deferred Revenue (Non-current)00000
Other Non-current Liabilities24.44M12.9M7.89M16.08M13.07M
Total Non-current Liabilities64.4M53.94M70.52M20.93M20.98M
Total Liabilities121.98M128.26M154.34M112.09M97.17M
Common Stock377K380K382K385K385K
Retained Earnings(131.87M)(158.41M)(210.86M)(395.2M)(429.2M)
Accumulated OCI3.15M1.36M(4.72M)(4.37M)(2.02M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity439.46M424.49M378.3M205.59M182.97M
Total Debt20M33.78M64.58M4.73M10.15M
Net Debt(28.16M)4.96M19.96M(71.33M)(45.75M)

AngioDynamics, Inc.

NASDAQ:ANGO

Intrinsic Alpha fair value

Locked

Current Price

$11.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.